Please use this identifier to cite or link to this item:
https://physrep.ff.bg.ac.rs/handle/123456789/1196
Title: | Modification and validation of an analytical source model for external beam radiotherapy Monte Carlo dose calculations | Authors: | Davidson, Scott E Cui, Jing Kry, Stephen Deasy, Joseph O Ibbott, Geoffrey S Vićić, Miloš White, R Allen Followill, David S |
Keywords: | clinical trial;Monte Carlo;source model | Issue Date: | Aug-2016 | Journal: | Medical physics | Abstract: | A dose calculation tool, which combines the accuracy of the dose planning method (DPM) Monte Carlo code and the versatility of a practical analytical multisource model, which was previously reported has been improved and validated for the Varian 6 and 10 MV linear accelerators (linacs). The calculation tool can be used to calculate doses in advanced clinical application studies. One shortcoming of current clinical trials that report dose from patient plans is the lack of a standardized dose calculation methodology. Because commercial treatment planning systems (TPSs) have their own dose calculation algorithms and the clinical trial participant who uses these systems is responsible for commissioning the beam model, variation exists in the reported calculated dose distributions. Today's modern linac is manufactured to tight specifications so that variability within a linac model is quite low. The expectation is that a single dose calculation tool for a specific linac model can be used to accurately recalculate dose from patient plans that have been submitted to the clinical trial community from any institution. The calculation tool would provide for a more meaningful outcome analysis. |
URI: | https://physrep.ff.bg.ac.rs/handle/123456789/1196 | ISSN: | 0094-2405 | DOI: | 10.1118/1.4955434 |
Appears in Collections: | Journal Article |
Show full item record
SCOPUSTM
Citations
6
checked on Oct 28, 2024
Page view(s)
26
checked on Nov 4, 2024
Google ScholarTM
Check
Altmetric
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.